MAOB and Parkinson disease: MAO-B inhibitors, such as l-deprenyl and rasagiline, show potential anti-dyskinetic and neuroprotective effects in PD zebrafish models (McKinley et al., 2005; Cronin and Grealy, 2017; Vaz et al., 2020).